Affinity Biologicals, Inc. FDA Record
- Latest inspection VAI · Jun 14, 2018
- No warning letters matched by name
Affinity Biologicals, Inc. has 0 FDA recalls, 2 inspections, 5 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Affinity Biologicals, Inc." is on file.
- Latest inspection
- Jun 14, 2018 · VAI
- Latest 510(k)
- Mar 6, 2016
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 5 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 2 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
Reviewing Affinity Biologicals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Affinity Biologicals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 14, 2018 | Ancaster, Canada | Devices | Voluntary Action Indicated (VAI) | 3003485232 |
| Jun 11, 2015 | Ancaster, Canada | Devices | Voluntary Action Indicated (VAI) | 3003485232 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3003485232 | Ancaster, Canada | 2 | Jun 14, 2018 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K150144 | VisuCon-F Low Fibrinogen Control Plasma | Mar 6, 2016 |
| K110432 | VISUCON-F FROZEN COAG SCREEN N, VISUCON-F FROZEN COAG SCREEN ABN | Oct 20, 2011 |
| K091284 | VISUCAL-F FROZEN CALIBRATOR PLASMA AND VISUCON-F FROZEN NORMAL AND ABNORMAL CONTROL PLASMA | Oct 28, 2009 |
| K052825 | VISULIZE FACTOR VIII ANTIGEN KIT, MODEL FVIII-AG | Jan 20, 2006 |
| K051054 | VISULIZE FACTOR IX ANTIGEN KIT | Jun 29, 2005 |
Affinity Biologicals, Inc. and the FDA: common questions
Has Affinity Biologicals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Affinity Biologicals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Affinity Biologicals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Affinity Biologicals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Affinity Biologicals, Inc.?
The most recent FDA inspection on file ended Jun 14, 2018 at Ancaster, Canada and was classified VAI. FDA has 2 inspections of Affinity Biologicals, Inc. on file.
Need more than this page shows? Ask about Affinity Biologicals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.